Purpose The purpose of this study was to demonstrate a sac angiography technique and evaluate the feasibility of N-butyl cyanoacrylate (NBCA) embolization of the ruptured abdominal aortic aneurysm (AAA) sac in emergency endovascular aneurysm repair (EVAR) in hemodynamically unstable patients. Methods A retrospective case series of three patients in whom sac angiography was performed during emergency EVAR for ruptured AAA was reviewed. After stent graft deployment, angiography within the sac of aneurysm (sac angiography) was performed by manually injecting 10 ml of contrast material through a catheter to identify the presence and site of active bleeding. In two patients, sac angiography revealed active extravasation of the contrast material, and NBCA embolization with a coaxial catheter system was performed to achieve prompt sealing. Results Sac angiography was successful in all three patients. In the two patients who underwent NBCA embolization for aneurysm sac bleeding, follow-up computed tomography (CT) images demonstrated the accumulation of NBCA consistent with the bleeding site in preprocedural CT images.
Introduction
Endovascular aneurysm repair (EVAR) of ruptured abdominal aortic aneurysms (r-AAAs) is feasible and offers the potential for decreased morbidity and mortality [1] [2] [3] . There also is currently an increased recognition of abdominal compartment syndrome [3] . Even after EVAR, ongoing bleeding from type II or IV endoleaks into the disrupted aneurysm sac in patients with severe coagulopathy may contribute to the size of the hematoma [3] .
Therefore, we developed a procedure for direct sealing of the bleeding site in the aneurysm sac during emergency EVAR as follows:
1. Sac angiography after stent-graft deployment was performed to evaluate the presence or absence of active bleeding from the aneurysm sac. 2. When the active bleeding continued, embolization using N-butyl cyanoacrylate was performed.
We herein introduce this technique of sac angiography in emergency EVAR and demonstrate our early experience with glue embolization during emergency EVAR in hemodynamically unstable patients with r-AAA.
Materials and Methods
Between September 2012 and October 2013, three consecutive patients (two men, one woman; mean age, 78 years; range 68-88 years) underwent sac angiography during emergency EVAR for r-AAA. All patients presented with abdominal pain and vital signs indicating hemodynamic instability. Hemodynamic instability was defined as loss of consciousness or a systolic blood pressure of \80 mm Hg despite ongoing resuscitation before induction of anesthesia. All patients were confirmed to have an r-AAA with active bleeding by contrast-enhanced computed tomography (CT). The average aneurysm diameter was 72 (range 70-75) mm, the average proximal aneurysm neck length was 24 (range 19-29) mm, and the proximal neck diameter was 21 (range 19-23) mm. Under our policy, the preferential treatment was EVAR. Open surgery was only selected as the treatment when anatomic criteria precluded effective exclusion of the aneurysm.
In this series, the Endurant Stent Graft System (Medtronic Cardiovascular, Santa Rosa, CA) was used in one patient, and the Excluder AAA Endoprosthesis (W. L. Gore & Associates, Flagstaff, AZ) was used in two patients (Table 1) .
Procedure
All endovascular procedures were performed in a hybrid operating room under fluoroscopy (Allura Xper FD20; Philips Medical Systems, Best, Netherlands). The procedures were started with percutaneous insertion of an aortic occlusion balloon catheter under local anesthesia as needed [4] . The patients then underwent general anesthesia and surgical exposure of their femoral arteries with or without aortic balloon occlusion.
Initially, the main body of the stent-graft was introduced through the contralateral access site (which was the opposite side of the occlusion balloon catheter) over a 0.035-inch stiff guidewire (Amplatz Extra-Stiff Wire; Cook Medical, Bloomington, IN) and deployed after the renal artery location was confirmed via aortography. The occlusion balloon catheter was then counterchanged through the main body side. After cannulation of the contralateral gate and exchange to a stiff wire, a 0.035-inch standard J guidewire (Terumo, Tokyo, Japan) was advanced into the sac of the aneurysm (between the stentgraft and native aorta) via the same sheath (18F Gore Ò DrySeal Sheath, W. L. Gore & Associates) in parallel with the stiff wire (Fig. 1B) . While maintaining the position of Table 1 Characteristics of hemodynamically unstable patients with ruptured AAA in whom sac angiography was performed the guidewire within the sac, the contralateral limb was introduced via the sheath onto the stiff wire and deployed (Fig. 1C) . Next, a 5-F Cobra catheter (FANSAC; Terumo) was advanced into the sac of the aneurysm onto the standard J guidewire via the same sheath (Fig. 1D ). Angiography within the sac of aneurysm (sac angiography) was then performed by manually injecting 10 ml of contrast material through the Cobra catheter to identify the presence and site of active bleeding. When sac angiography revealed no active bleeding, glue embolization was not performed (Fig. 2) . When sac angiography demonstrated active extravasation of the contrast material (Fig. 3B) , a microcatheter (Wonder III; UTM Co. Ltd., Nagoya, Japan) and a 0.016-inch guidewire (AQUA V-III; Cordis, Miami Lakes, FL) were coaxially advanced into the ruptured hole of the aneurysm. After confirming the position by selective angiography, embolization using a 50 % mixture of N-butyl cyanoacrylate (NBCA) (B. Braun, Melsungen, Germany) and iodized oil (Lipiodol Ultra-Fluid; Terumo) was performed (Fig. 3C) . Just before the NBCA mixture was injected, the Fig. 1 Methodology of sac angiography in emergency EVAR in hemodynamically unstable patients with a ruptured AAA. A Active bleeding from the aneurysm sac was seen in a patient with a ruptured AAA. The white arrow indicates the bleeding site. B After a main body stent-graft was deployed, cannulation of the contralateral gate was performed. Another guidewire (white arrow) was then advanced into the sac of the aneurysm through the same sheath (black arrow) in parallel. C While maintaining the position of the guidewire (white arrow), the contralateral limb stent-graft was deployed. D A 5-F catheter was advanced into the sac of the aneurysm onto the guide wire (white arrow). Angiography within the sac of the aneurysm (sac angiography) using the catheter was then performed to assess the presence or absence of active bleeding Fig. 2 Angiography within the sac of the aneurysm (sac angiography) revealed no active bleeding microcatheter was flushed with a 5 % glucose solution to prevent polymerization within the microcatheter. The NBCA was injected slowly into the ruptured hole through a microcatheter, and the microcatheter was immediately retracted to prevent adherence of the catheter tip to the artery wall.
Finally, balloon dilation of the proximal neck, docking zone, and iliac legs was performed for adequate sealing of the stent-graft.
Results
Sac angiography was successfully performed in all three patients. Active bleeding from the aneurysm sac was observed in two patients (Patient 2 with Endurant and Patient 3 with Excluder), and subsequent embolization using an NBCA mixture was performed. In both cases, approximately After the procedures, major complications were reported in all three patients: respiratory failure in two and renal insufficiency in one. After a mean hospital stay of 29 (range 11-45) days, all three patients were discharged.
During the follow-up (mean 8 months; range 6-12 months), CT angiography revealed no evidence of endoleaks or stent-related problems. An accumulation of the NBCA was recognized, consistent with the bleeding site (Fig. 3D) . 
Discussion
In this technical report, we described the methodology of sac angiography in emergency EVAR for r-AAA and NBCA embolization to occlude the bleeding site in the aneurysm sac. Follow-up CT images demonstrated an accumulation of the NBCA consistent with the bleeding site, which indicated technical success.
Although EVAR in the treatment of r-AAAs seems to be feasible [1] [2] [3] , it has a potential disadvantage associated with endoleaks, which could be undesirable in cases of active bleeding. Continuous bleeding via endoleaks may exacerbate hemorrhagic shock and abdominal compartment syndrome [3, 5] .
To our knowledge, there are no reports on the performance of embolization of a bleeding site to achieve rapid hemostasis in a patient with r-AAA. To reduce the risk of type II endoleaks in elective EVAR, previous reports demonstrated intrasac ''thrombization'' using fibrin glue injection with or without the insertion of coils [6, 7] . However, because patients with r-AAA frequently also have severe coagulation abnormalities, NBCA seems to be a more feasible embolic material [8, 9] . In addition, a previous report described successful glue embolization of an r-AAA by a late type I endoleak after EVAR [10] . In the two cases, EVAR with NBCA embolization achieved prompt sealing with disappearance of the extravasation of contrast material as shown on the angiogram and an accumulation of NBCA as shown on the postoperative CT images. In emergent EVAR with active bleeding, we advocate that additional glue embolization is feasible.
The percentage of endoleaks after EVAR is generally reported to be 20-30 %, but endoleaks may be more common than previously believed [11, 12] . That is, completion aortography sometimes fails to detect the presence of endoleaks. Therefore, we performed sac angiography to evaluate the presence or absence of active bleeding before aortography to detect the presence of endoleak. When the active bleeding continued, following embolization would achieve prompt hemostasis.
A potential complication associated with the use of NBCA is distal ischemic injury from nontarget glue embolization [10] . This risk can be minimized by coaxial microcatheterization of the rupture point after deployment of the stent-graft. However, this is associated with a risk of colonic or spinal cord ischemia [10, 13, 14] .
In the two cases, either one or no bleeding site was demonstrated in the aneurysm sac by sac angiography. In patients with several bleeding sites in the aneurysm, embolization to fill the entire aneurysm sac may be required.
This small, retrospective series included patients who underwent sac angiography during emergency EVAR. Because patients who undergo r-AAA treatment are in severe conditions, it is difficult to demonstrate the feasibility of sac angiography and NBCA embolization of the bleeding site. Nonetheless, occlusion of the bleeding site in the aneurysm sac of the r-AAA in addition to the performance of EVAR may represent a possible technical improvement of conventional EVAR. Sac angiography would be of value as the basis for embolization of the bleeding site.
In conclusion, EVAR is associated with the potential risk of ongoing bleeding from type II or IV endoleaks into the disrupted aneurysm sac in patients with severe coagulopathy. Therefore, sac angiography and NBCA embolization during emergency EVAR may represent a possible technical improvement in the treatment of r-AAA in hemodynamically unstable patients.
